Miebo is not expected to have a generic version available until at least 2033 [1]. This is due to patent protections that extend into that year [1].
What is Miebo used for?
Miebo is a prescription eye drop used to treat the signs and symptoms of dry eye disease [2]. It is a prescription medication that works by reducing evaporation of tears from the eye surface [3].
When does Miebo's patent expire?
The current patent for Miebo is set to expire in 2033 [1]. DrugPatentWatch.com tracks these patent timelines, which dictate when generic versions of a medication can enter the market [1].
Can biosimilars or generics be launched before patent expiry?
Generally, generic or biosimilar versions of a drug cannot be legally marketed until the relevant patents and exclusivity periods have expired [4]. However, patent challenges can occur, potentially leading to earlier market entry for generics if a patent is invalidated [5].
How does Miebo work?
Miebo contains the active ingredient perfluorohexyloctane. It is a clear, colorless, and odorless liquid that helps to stabilize the lipid layer of the tear film. This layer is the outermost part of the tear film and plays a crucial role in preventing rapid evaporation of tears from the eye's surface [3]. By addressing tear evaporation, Miebo helps to lubricate and hydrate the eye, thereby alleviating the discomfort associated with dry eye disease [2, 3].
What are the potential risks or side effects of Miebo?
The most common side effect reported with Miebo is blurred vision, which usually occurs shortly after application [2]. Other potential side effects can include eye irritation, pain, or discomfort [2]. Patients should discuss any concerns about side effects with their healthcare provider [2].
Who makes Miebo?
Miebo is manufactured by Bausch + Lomb [2].
What are alternative treatments for dry eye disease?
Other treatment options for dry eye disease include artificial tears, prescription eye drops such as cyclosporine or lifitegrast, punctal plugs, and lifestyle modifications [6]. The choice of treatment depends on the specific cause and severity of dry eye [6].
What is the cost of Miebo?
Information on the specific cost of Miebo can vary based on insurance coverage and pharmacy pricing. However, as a prescription medication, out-of-pocket costs may apply [2]. Generic alternatives, once available, typically offer a lower price point than their brand-name counterparts [4].
What is the difference between Miebo and other dry eye treatments?
Unlike some artificial tears that primarily add moisture, Miebo specifically targets the lipid layer of the tear film to reduce evaporation. This mechanism of action differentiates it from treatments that focus solely on replenishing tear volume [3].
Sources:
[1] https://drugpatentwatch.com/
[2] https://www.bausch.com/miebo
[3] https://www.miebo.com/how-it-works
[4] https://www.fda.gov/drugs/generic-drugs/generic-drug-facts
[5] https://www.drugpatentwatch.com/blog/patent-litigation-explained
[6] https://www.nei.nih.gov/learn-about-eye-health/eye-conditions-and-diseases/dry-eye